Article

Satraplatin or active metabolite kills prostate cancer in vitro

Treatment of prostate cancer cells with satraplatin or its active metabolite resulted in the killing of tumor cells, according to a poster presented at the American Association for Cancer Research's Basic, Translational, and Clinical Advances in Prostate Cancer meeting.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

© 2025 MJH Life Sciences

All rights reserved.